Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 285

1.

Left atrial appendage occlusion: opportunities and challenges.

Holmes DR Jr, Lakkireddy DR, Whitlock RP, Waksman R, Mack MJ.

J Am Coll Cardiol. 2014 Feb 4;63(4):291-8. doi: 10.1016/j.jacc.2013.08.1631. Epub 2013 Sep 27. Review.

2.

Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.

Yan BP, Kiernan TJ, Gonzales-Cruz I, Lam YY.

Expert Rev Med Devices. 2009 Nov;6(6):611-20. doi: 10.1586/erd.09.45. Review.

PMID:
19911873
3.

Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY.

J Am Coll Cardiol. 2014 Jul 8;64(1):1-12. doi: 10.1016/j.jacc.2014.04.029. Erratum in: J Am Coll Cardiol. 2014 Sep 16;64(11):1186.

4.

The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.

Ramlawi B, Abu Saleh WK, Edgerton J.

Methodist Debakey Cardiovasc J. 2015 Apr-Jun;11(2):100-3. doi: 10.14797/mdcj-11-2-100. Review.

5.

Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.

Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D; PROTECT AF Investigators.

Circulation. 2013 Feb 12;127(6):720-9. doi: 10.1161/CIRCULATIONAHA.112.114389. Epub 2013 Jan 16.

6.

Non-surgical left atrial appendage closure for stroke prevention in atrial fibrillation.

Friedman PA, Holmes DR.

J Cardiovasc Electrophysiol. 2011 Oct;22(10):1184-91. doi: 10.1111/j.1540-8167.2011.02172.x. Epub 2011 Sep 13. Review.

PMID:
21914028
7.

Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.

Price MJ, Reddy VY, Valderrábano M, Halperin JL, Gibson DN, Gordon N, Huber KC, Holmes DR Jr.

JACC Cardiovasc Interv. 2015 Dec 28;8(15):1925-1932. doi: 10.1016/j.jcin.2015.08.035. Epub 2015 Nov 25.

8.

Left Atrial Appendage Occlusion Device and Novel Oral Anticoagulants Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Briceno DF, Villablanca P, Cyrille N, Massera D, Bader E, Manheimer E, Aagaard P, Ferrick K, Gross J, Kim SG, Krumerman A, Palma E, Guttenplan N, Romero J, Fisher J, Garcia M, Natale A, Di Biase L.

Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1057-64. doi: 10.1161/CIRCEP.115.002993. Epub 2015 Jul 30. Review.

9.

Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device.

Möbius-Winkler S, Schuler GC, Sick PB.

Curr Opin Neurol. 2008 Feb;21(1):64-9. doi: 10.1097/WCO.0b013e3282f419b6. Review.

PMID:
18180653
10.

Left atrial appendage closure.

Lin AC, Knight BP.

Prog Cardiovasc Dis. 2015 Sep-Oct;58(2):195-201. doi: 10.1016/j.pcad.2015.07.009. Epub 2015 Aug 1. Review.

PMID:
26241302
11.

Nonpharmacologic approaches to stroke prevention in atrial fibrillation.

Whitlock RP, Hanif H, Danter M.

Can J Cardiol. 2013 Jul;29(7 Suppl):S79-86. doi: 10.1016/j.cjca.2013.04.004. Review.

PMID:
23790602
12.

Atrial fibrillation and stroke management: present and future.

Holmes DR.

Semin Neurol. 2010 Nov;30(5):528-36. doi: 10.1055/s-0030-1268861. Epub 2011 Jan 4. Review.

PMID:
21207345
13.

Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation.

Chiam PT, Ruiz CE.

J Invasive Cardiol. 2008 Apr;20(4):E109-13. Review.

PMID:
18398240
14.

Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion.

Lewalter T, Kanagaratnam P, Schmidt B, Rosenqvist M, Nielsen-Kudsk JE, Ibrahim R, Albers BA, Camm AJ.

Europace. 2014 May;16(5):626-30. doi: 10.1093/europace/euu069. Review.

PMID:
24798956
15.

Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.

Grosset-Janin D, Barth E, Bertrand B, Detante O.

Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23. Review.

PMID:
25912470
16.

Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.

Alli O, Doshi S, Kar S, Reddy V, Sievert H, Mullin C, Swarup V, Whisenant B, Holmes D Jr.

J Am Coll Cardiol. 2013 Apr 30;61(17):1790-8. doi: 10.1016/j.jacc.2013.01.061. Epub 2013 Feb 28.

17.

Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.

Syed TM, Halperin JL.

Nat Clin Pract Cardiovasc Med. 2007 Aug;4(8):428-35. Review.

PMID:
17653115
18.

The WATCHMAN left atrial appendage closure device for atrial fibrillation.

Möbius-Winkler S, Sandri M, Mangner N, Lurz P, Dähnert I, Schuler G.

J Vis Exp. 2012 Feb 28;(60). pii: 3671. doi: 10.3791/3671.

19.

Evaluation of the WATCHMAN left atrial appendage closure device.

Alli O, Holmes D Jr.

Expert Rev Med Devices. 2014 Nov;11(6):541-51. doi: 10.1586/17434440.2014.940315. Epub 2014 Jul 25. Review.

PMID:
25060590
20.

Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation.

Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, Mishkel G, Almany S, Holmes DR.

J Am Coll Cardiol. 2007 Apr 3;49(13):1490-5. Epub 2007 Mar 21.

Supplemental Content

Support Center